PURPOSE: Acupuncture is a complementary and alternative medicine (CAM) modality that shows promise as a component of supportive breast cancer care. Lack of robust recruitment for clinical trial entry has limited the evidence base for acupuncture as a treatment modality among breast cancer survivors. The objective of this study is to identify key decision-making factors among breast cancer survivors considering entry into an acupuncture clinical trial for treatment of symptoms. METHODS: Semistructured interviews were conducted among African-American (n=12) and Caucasian (n=13) breast cancer survivors. Verbatim transcripts were made and analyzed by two or more independent coders using NVivo software. Major recurring themes were identified and a theoretical framework developed. RESULTS: Six themes emerged reflecting key attributes of the decision to enter a clinical trial: (1) symptom appraisal, (2) practical barriers (e.g., distance and travel), (3) beliefs about the interventions (e.g., fear of needles and dislike of medications), (4) comfort with elements of clinical trial design (e.g., randomization, the nature of the control intervention, and blinding), (5) trust, and (6) altruism. African-American and Caucasian women weighed similar attributes but differed in the information sources sought regarding clinical trial entry and in concerns regarding the use of a placebo in a clinical trial. CONCLUSIONS: Our findings contribute to the development of a theoretical model of decision making for breast cancer survivors considering participation in a CAM clinical trial. Insights regarding the decision making process can inform interventions to support informed decision making and robust recruitment to CAM trials among cancer survivors.
PURPOSE: Acupuncture is a complementary and alternative medicine (CAM) modality that shows promise as a component of supportive breast cancer care. Lack of robust recruitment for clinical trial entry has limited the evidence base for acupuncture as a treatment modality among breast cancer survivors. The objective of this study is to identify key decision-making factors among breast cancer survivors considering entry into an acupuncture clinical trial for treatment of symptoms. METHODS: Semistructured interviews were conducted among African-American (n=12) and Caucasian (n=13) breast cancer survivors. Verbatim transcripts were made and analyzed by two or more independent coders using NVivo software. Major recurring themes were identified and a theoretical framework developed. RESULTS: Six themes emerged reflecting key attributes of the decision to enter a clinical trial: (1) symptom appraisal, (2) practical barriers (e.g., distance and travel), (3) beliefs about the interventions (e.g., fear of needles and dislike of medications), (4) comfort with elements of clinical trial design (e.g., randomization, the nature of the control intervention, and blinding), (5) trust, and (6) altruism. African-American and Caucasian women weighed similar attributes but differed in the information sources sought regarding clinical trial entry and in concerns regarding the use of a placebo in a clinical trial. CONCLUSIONS: Our findings contribute to the development of a theoretical model of decision making for breast cancer survivors considering participation in a CAM clinical trial. Insights regarding the decision making process can inform interventions to support informed decision making and robust recruitment to CAM trials among cancer survivors.
Authors: Jean G Ford; Mollie W Howerton; Gabriel Y Lai; Tiffany L Gary; Shari Bolen; M Chris Gibbons; Jon Tilburt; Charles Baffi; Teerath Peter Tanpitukpongse; Renee F Wilson; Neil R Powe; Eric B Bass Journal: Cancer Date: 2008-01-15 Impact factor: 6.860
Authors: Primo N Lara; Debora A Paterniti; Christine Chiechi; Corinne Turrell; Claudia Morain; Nora Horan; Lisa Montell; Jose Gonzalez; Sharon Davis; Ari Umutyan; Cynthia L Martel; David R Gandara; Ted Wun; Laurel A Beckett; Moon S Chen Journal: J Clin Oncol Date: 2005-12-20 Impact factor: 44.544
Authors: E J Robinson; C E P Kerr; A J Stevens; R J Lilford; D A Braunholtz; S J Edwards; S R Beck; M G Rowley Journal: Health Technol Assess Date: 2005-03 Impact factor: 4.014
Authors: Maria A Hondras; Cynthia R Long; Andrea G Haan; Lori Byrd Spencer; William C Meeker Journal: J Altern Complement Med Date: 2008-10 Impact factor: 2.579
Authors: Sandra E Brooks; Randy L Carter; Steven C Plaxe; Karen M Basen-Engquist; Michael Rodriguez; James Kauderer; Joan L Walker; Tashanna K N Myers; Janet G Drake; Laura J Havrilesky; Linda Van Le; Lisa M Landrum; Carol L Brown Journal: Gynecol Oncol Date: 2015-04-30 Impact factor: 5.482
Authors: Carolyn Ee; Anna C Singleton; Michael de Manincor; Elisabeth Elder; Nikki Davis; Christine Mitchell; Tinashe Dune; Freya MacMillan; Kate McBride; Suzanne Grant Journal: Integr Cancer Ther Date: 2022 Jan-Dec Impact factor: 3.077
Authors: Ai Kubo; Elaine Kurtovich; MegAnn McGinnis; Sara Aghaee; Andrea Altschuler; Charles Quesenberry; Tatjana Kolevska; Andrew L Avins Journal: Integr Cancer Ther Date: 2019 Jan-Dec Impact factor: 3.279
Authors: Ai Kubo; Sara Aghaee; Elaine M Kurtovich; Linda Nkemere; Charles P Quesenberry; MegAnn K McGinnis; Lyndsay A Avalos Journal: Mindfulness (N Y) Date: 2021-03-11